In this research study, Cemiplimab is being evaluated as a treatment for advanced cutaneous
squamous cell carcinoma in participants who have previously received an allogeneic
hematopoietic stem cell transplant or kidney transplant.
- This research study involves the following drug(s):
- Cemiplimab
- Everolimus or Sirolimus
- Prednisone